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 Abstract —The use of CMOS platforms in medical point-of-care 
applications, by integrating all steps from sample to data output, 
has the potential to reduce the diagnostic cost and the time from 
days to seconds.  Here we present the ‘Multicorder’ technology, 
a handheld versatile multimodal platform for rapid metabolites 
quantification. The current platform is composed of a cartridge, 
a reader and a graphic user interface. The sensing core of the 
cartridge is the CMOS chip which integrates a 16x16 array of 
multi-sensor elements. Each element is composed of two optical 
and one chemical sensor. The platform is therefore capable of 
performing multi-mode measurements: namely colorimetric, 
chemiluminescence, pH sensing and surface plasmon resonance. 
In addition to the reader that is employed for addressing, data 
digitization and transmission, a tablet computer performs data 
collection, visualization, analysis and storage. In this paper, we 
demonstrate colorimetric, chemiluminescence and pH sensing 
on the same platform by on-chip quantification of different 
metabolites in their physiological range. The platform we have 
developed has the potential to lead the way to a new generation 
of commercial devices in the footsteps of the current commercial 
glucometers for quick multi-metabolite quantification for both 
acute and chronic medicines. 
Keywords —CMOS, Metabolomics, diagnostics, point-of-care, 
lab-on-chip, Photodiodes, SPAD, ISFET.  
 
I. INTRODUCTION 
The need for portable diagnostic devices is a shared vision 
[1-3]. In the science-fictional Start-Trek universe, a portable 
multi-function analyzer, called the ‘Tricorder’, was able to 
instantly diagnose medical conditions in seconds. Sixty years 
after the show, Star Trek’s fictional device is maybe not too 
far from becoming a reality. In fact, metabolomics – the study 
of the small molecules (metabolites) produced by human cells 
during the metabolism - promises to succeed where 
proteomics and genomics strive to overcome major 
challenges [4, 5]. Nowadays, more than 114000 metabolites 
have been detected in body fluids, tissues and organs and 
more than 4200 in human serum only [6]. The increasing 
interest in metabolomics is related to its capability of 
describing the phenotype: while genomics describes what 
‘could happen’ in the organism (genotype), the metabolome 
is affected by both genetic and environmental factors, 
providing a direct functional readout of the physiological 
state of the organism [7, 8]. It is not a case that the best-selling 
drugs act somehow on metabolic pathways [9]. 
Metabolomics-based point-of-care devices have already 
demonstrated their world-changing capabilities in a wide 
range of applications. Glucose monitoring handheld devices, 
for examples, have massively improved life quality for 
people affected by diabetes [10]. Similar handheld units are 
also commonly employed in roadside alcohol monitoring 
[11]. Cholesterol and lactate meters are also getting 
progressively popular [12].  
However, due to the huge diversity of chemical structures, to 
date, there is no single technology available to analyze the 
entire metabolome [7].  On the contrary, metabolomics 
devices usually employ single-modality bench-top laboratory 
instruments such as nuclear magnetic resonance 
spectroscopy, gas and liquid chromatography-mass 
spectrometry and spectrophotometry [9]. Each technique 
provides different advantages/disadvantages widely 
discussed in the literature [9]. 
The advancement of complementary metal oxide 
semiconductor (CMOS) technology has produced a dramatic 
impact on portable and low-cost biomedical sensing 
applications [13]. The most commonly used sensing 
techniques in point-of-care applications are optical and 
electrochemical, where CMOS technology has been 
successfully employed. Photodiode (PD) arrays have been 
employed for colorimetric [14] and fluorescence detection 
[15]. CMOS-based Single Photon-Avalanche Diodes 
(SPADs) have been successfully employed for auto-
fluorescence and chemiluminescence measurements [16]. 
CMOS technology has also been utilized for Surface Plasmon 
Resonance (SPR) measurements [17] and ISFET-based DNA 
sequencing [18]. Also, Electrochemical microelectrode 
arrays have been demonstrated to be suitable for metabolites 
detection [19].  
In the last decade, as a result of the maturity of the 
technology, a large interest in multimodal CMOS chip has 
risen.  A multimodal chip is a microelectronic integrated 
circuit suitable for more than one sensing technique. For 
instance, an ISFET and PD array has been utilized for 
improved DNA sequencing in a dual-mode CMOS chip [20].  
Also, a combination of PDs, electrodes and LEDs have been 
shown for neural imaging [21].  
In this manuscript, we present a scalable multi-sensor 
platform for rapid multimodal metabolite sensing: the 
‘Multicorder’. The core of the platform is a CMOS 16x16 
array of multi-sensor elements. Each element integrates a PD, 
a SPAD and an ISFET that can be utilized independently or 
simultaneously. Thus, the Multicorder can be used for multi-
modalities measurements. The sensors were implemented in 
an array format so that measurements can be averaged to 
reduce noise and increase accuracy. We believe this platform 
could enable a new generation of commercial devices in the 
footsteps of the current commercial glucometers for quick 
multi-metabolite quantification for both acute and chronic 
medicine.  
The rest of this paper is organized as follows: in section II, 
the architecture of the platform is described. Section III 
describes the performance of the sensors. Section IV shows 
the capability of the platform in different modalities by 
quantifying different metabolite concentrations within the 
physiological range. Section V concludes the paper.  
 
II. THE MULTICORDER PLATFORM  
The Multicorder platform is made of 3 sub-units: the 
cartridge, the reader and the Graphic User Interface (GUI) 
(Fig. 1).  The versatility of the Multicorder resides in the 
possibility of functionalizing the chip-surface for the target 
application. At the current state, a wide range of biological 
tests has been developed on-chip with minimal modifications 
of the cartridge only. The reader is composed of a PCB and a 
microcontroller. The reader is employed for addressing, data 
digitization and data transmission to the GUI via a USB link. 
The GUI is a software running on a tablet computer allowing 
user interaction.  
 
A. The Cartridge  
The cartridge of the development platform includes the 
CMOS chip with post-processing, chip packaging and 
biological receptors. In the final vision of the project, the 
cartridge will be disposable and pre-functionalized with 
relevant bio-receptors. However, in this work due to limited 
resources, the cartridges have been refurbished after use in 
order to be reused many times. The Multicorder chip 
integrates a 16 x 16 array of multi-sensor elements, each 
comprising a PD, SPAD and ISFET sensor, for a total of 256 
elements and 768 sensors. 
 
The chip was fabricated using a commercially available 
CMOS 350 nm HV 4-metal process provided by AMS. The 
chip size is 3.4 x 3.6 mm. The size of the multi-sensor element 
is 110 µm x 110 µm. This arrangement ensures an even 
distribution of each modality sensors across the active area of 
the chip. The chip circuitry includes addressing to allow each 
sensor array to be controlled and operated either 
independently or simultaneously (see Fig. 2). Specifically, 
each sensor can be addressed using two 4 – 16 decoders. PDs 
and ISFETs have analogue outputs. Differently, SPAD 
outputs are digital since the chip has embedded counters. In 
order to improve the performance of the ISFET sub-array, the 
chip was post-processed [23].   
After post-processing, the CMOS chip is wire bonded and 
packaged into a ceramic chip carrier. Wire bonds are usually 
encapsulated with epoxy resin (302-3M 1LB) to provide 
mechanical strength and protection. A culture ring is also 
glued to the ceramic chip carrier and sealed with epoxy resin 
allowing solution assays. Micrograph pictures of the 
cartridge are reported in Fig. 3 
The biological receptors used are related to the target analyte. 
In general, specific receptors are used in order to trigger a 
biochemical reaction with the metabolite to be quantified. 
The specific reaction produces a change in the biophysical 
properties of the sample that can be quantified by a sensor. 
Examples of physical changes induced by the reaction are 
light absorbance or pH modifications. The rate and the 
endpoint of the reaction are usually related to the 
concentration of the analyte under test. The employed 
biological receptors utilized in the data presented in this 
manuscript are reported in the results section (Section IV).  
 
Fig.1. Architecture of the platform. The platform is made up of three sub-units: the cartridge, the reader and the GUI. 
B. The Reader and the GUI  
The reader is made up by a PCB board and a microcontroller 
(see Fig. 4). The PCB board allows connecting the cartridge 
in a very user-friendly mode by employing a Zero Insertion 
Force (ZIF) socket. The output of the sensor is driven by the 
microcontroller. The microcontroller is dedicated to the 
addressing of the array, data digitalization and data 
transmission to the GUI by USB link. The USB link also 
provides power for the chip and the Mbed processor. The ST 
Nucleo F334R8 board was employed and programmed with 
custom firmware. In this work, PD data is digitized with a 12-
bit ADC at 16 frames per second (fps). ISFET data is 
digitized with the same number of bit but the reading cycle is 
shorter and a higher frame rate is achieved (42 fps). 
Differently, SPAD data does not need digitization (output 
data is already digital).  
 
 
 
Fig. 2. Block-diagram of the CMOS chip, describing the independent 
addressing and read-out architecture of each sensing technique.  
 
 
 
(a) (b) (c) 
 
Fig. 3. Micrograph of the multimodal sensor array: (a) Cartridge after wire-
bonding to the chip carrier, (b) CMOS chip, (c) Multi-sensor elements.  
 
 
   
(a) (b) 
 
Fig. 4. Demonstrative pictures of the reader. (a) The cartridge is connected 
using a Zero Insertion Force socket. The cartridge package is also adapted 
for assays in solutions. (b) The Multicorder platform is portable and can be 
hand held.  
The GUI is a software running on an electronic device with 
USB communication and graphics capabilities. In this work, 
we successfully used a tablet and a computer. The GUI 
performs data collection, visualization, analysis, storage and 
uploads the final test result onto a cloud via Wi-Fi. 
 
III. SENSORS PERFORMANCE  
The sensors were independently characterized.  
To test the dynamic range of the optical devices a 
monochromator was configured at a wavelength of 550 nm 
and attached to an optical integrating sphere to ensure 
uniform light distribution. An optical power meter (1936-R, 
Newport, USA) was fitted to one exit port to measure the light 
intensity and the CMOS chip was placed at another exit port. 
In dark conditions, the output of the PD was 408 mV because 
of the dark current. The measured dynamic range for the 
photodiode was 0.05 - 4.9 µW/cm2. Photodiode responsivity 
at 550 nm was 21.6 mV/µW. The SPAD dynamic range was 
measured similarly and with the same light wavelength. The 
SPAD array was activated and biased at 21.5 V, 3 V above 
its breakdown voltage. The measured dynamic range for the 
SPAD was 0.45 - 600 nW/cm2. SPAD photon detection 
probability peak at 475 nm was 41 %. In dark conditions, the 
SPAD produced a dark count rate (DCR) of 10 kcps.  
To evaluate the ISFET pH dynamic range and sensitivity, the 
chip was tested with five buffer solutions (pH 5, 6, 7, 8, 9).  
A silver/silver chloride (Ag/AgCl) reference electrode was 
used biased at ~1.3 V with respect to the ISFET source 
voltage. Prior to testing the sensor, the chip was washed with 
DI water, dried with N2 and then tested in the pH 9 buffer to 
establish a baseline. The data showed a pH sensitivity of 33 
mV/pH with a linear response between pH 5 and pH 9 when 
tested against a commercial pH probe (HI5522, HANNA 
instruments). 
The noise source in CMOS sensors array can be divided into 
fixed pattern noise (FPN) and temporal noise [24]. While 
FPN is the variation of the output among elements when the 
same input is applied, temporal noise introduces variability in 
measurements from the same sensor. In general, there are 3 
different sources of temporal noise found within the sensors 
namely, flicker noise (also known as 1/f noise), shot noise 
and thermal noise. Based on the physical nature of the sensor 
one of these noise components dominates the others dictating 
the signal distribution.  Flicker noise is a very low frequencies 
disturbance which is modelled as a function of 1/f, where f is 
the frequency [25].  Thermal noise is Gaussian noise with a 
broadband frequency spectrum which is usually restricted to 
the sensor spectrum. Shot noise is generated by a carrier 
crossing a p-n barrier and it usually results in a DC current, 
such as the dark current of a photodiode or the leakage current 
of a diode [25, 26]. Each of our sensors is affected by all three 
components in different ways, ISFET is primarily affected by 
thermal noise and flicker noise while shot noise is largely 
predominant in PD and SPAD. By exploiting the fact that the 
above-mentioned noise sources can be modelled as Gaussian 
distribution [27], averaging the readout of each array reduces 
the standard deviation and therefore produce more reliable 
results. The averaging process proved to effectively reduce 
the disturbance as a function of 1/√N, where N is averaged 
population. 
IV. MULTIMODAL BIOLOGICAL EXPERIMENTS   
We performed biological experiments for metabolite 
quantifications in order to demonstrate the chip capability to 
perform different sensing modalities. 
In this manuscript, we demonstrate the use of three 
modalities: colorimetric, chemiluminescence and pH sensing.  
Additionally, the platform was used also for Surface Plasmon 
Resonance (SPR) [28, 29]. Altogether, the chip demonstrated 
to be suitable for four different sensing modalities. 
The developed biological assay employs reagents which react 
with the target analyte hence modifying the initial biophysical 
properties of the solution. The concentration of the target 
analyte can be determined by estimating the rate of the 
reaction using the Michaelis-Menten model [30]. Data shown 
in this section are averaged over the entire array and the test 
is concluded in minutes.  
 
A. Colorimetric 
A colorimetric assay utilizes specific reagents that undergo a 
measurable and progressive light absorbance change at a 
specific wavelength. In this manuscript, we report 
colorimetric measurement to quantify concentrations of 
cholesterol.   
A two-step reaction chain has been implemented. First, a 
reaction between cholesterol and cholesterol oxidase was 
induced. This reaction produces hydrogen peroxide (H2O2).  
The produced H2O2 was used as a substrate to oxidase 
o-dianisidine together with peroxidase. Oxidized 
o-dianisidine shows higher light absorbance at 500 nm. Thus, 
as the reaction proceeds, the light absorbance of the reaction 
changes and this physical change can be detected by PDs 
when illumined with constant green light from a 
monochromator at 500 nm. The setup for this method is 
shown in Fig. 5.  
Before the measurement, the chip was cleaned with standard 
procedures (acetone, isopropyl alcohol and sonication).  
Afterwards, a mixture solution of triethanolamine (830 µl 20 
mM), cholesterol (40 µl 10 mM in 10% (w/v) Triton X-100), 
peroxidase enzyme (50 µl 60 U/ml) and o-dianisidine (40 µl 
7.89 mM) was placed onto the sensor surface. The pH of the 
solution was 8.5.  
 
 
 
 
 
Fig 5. Setup for colorimetric mode. The light absorbance change generated 
by a specifically designed reaction was measured by PDs. 
After a stable baseline was obtained, 40 µl 10 U/ml 
cholesterol oxidase enzyme solution was added to initiate the 
reaction. Two concentrations of cholesterol (25 µM and 400 
µM) were measured. This range covers the cholesterol 
physiological range in human blood (< 4.1 mM) [31].  
Figure 6 shows the PDs output for the performed 
experiments. Increasing the concentration of the target 
analyte creates a detectable increment in the rate of the 
reaction w.r.t. the control.  
Choline, xanthine and sarcosine have also been quantified 
with this technique on the same platform and reported into 
related works [32].  
 
B. Chemiluminescence 
A Chemiluminescence assay employs specific reagents to 
create a progressive light emission during the reaction. In this 
manuscript, we demonstrate chemiluminescence 
measurement by quantifying urate.  
Similarly to colorimetric mode, a two-step reaction chain was 
utilized. First, the urate-uricase enzymatic reaction was used 
to produce H2O2. Next, the produced H2O2 was used as a 
substrate to react with Luminol.  Under the catalytic activity 
of peroxidase, the reaction Luminol - H2O2 emits a small 
number of photons. The generated blue light was detected by 
SPADs. The setup of the chemiluminescence is depicted in 
Fig. 7.  
After standard cleaning procedures, a mixture solution of 900 
µl 100 µM urate in 50 mM triethanolamine pH 8.5, 50 µl 60 
U/ml peroxidase enzyme solution, and 50 µl 8 mM luminol 
solution was placed onto the sensor surface. After a stable 
baseline was obtained, 50 µl 1 U/ml Uricase enzyme solution 
was added to initiate the reaction. 
Two concentrations of urate (100 µM and 1 mM) and one 
control measurement were used to demonstrate the 
quantification in the physiological range (200 µM –500 µM) 
[33]. Figure 8 shows the SPADs output for the performed 
experiments. Confirming that, increasing the concentration of 
the target analyte creates a detectable increment in the rate of 
the reaction w.r.t. the control. It is worth noticing that the 
same measurement could not be performed employing PDs 
because the light intensity was below the PD sensitivity range 
 
 
 
 
Fig 6. Cholesterol quantification using the colorimetric technique. Data is 
averaged over the entire array. The test is completed in minutes.  
 
 
Fig 7. Setup for chemiluminescence mode. A specific reagent mix reacts with 
the analyte under test producing a small amount of light. The produced light 
was detected by SPADs.  
 
 
Fig 8. Urate quantification using the chemiluminescence technique. Data is 
averaged over the entire array. The test is completed in minutes.  
 
 
 
Fig 9. Setup for pH sensing. A specific reagent mix reacts with the analyte 
under test producing a pH change. The produced pH was measured by 
ISFETs. 
 
 
Fig 10. Urea quantification by pH sensing. Data is averaged over the entire 
array. The test is completed in minutes.  
 
C. pH sensing 
The pH-based assay employs specific reagents to create a 
progressive pH change during the reaction. In this 
manuscript, we demonstrate pH sensing mode by quantifying 
urea.  
A single step reaction was utilized in these experiments. A 
chemical reaction between urea and urease was started in 
order to produce ions (such us H+). The progressive 
production of ions creates a pH change. Urea-urease activity 
tends to increase the pH of its solution as it produces 
ammonia, which is a basic molecule. Therefore, ISFETs were 
employed for pH-based sensing. The setup of the performed 
experiments is shown in Fig. 9.  
After the standard cleaning of the chip, the potential of the 
Ag/AgCl reference electrode was set to 0 V. To start the 
experiment, 950 µl 30 mM urea in 50 mM triethanolamine 
pH 8.5 was firstly placed on the sensor surface. After a stable 
baseline was obtained, 50 µl 80 Units/ml urease enzyme 
solution was added to initiate the reaction.  
Two concentrations of urea (2 mM and 30 mM) and one 
control measurement were used to demonstrate the 
performance of the ISFET. A decrease in the electrical signal 
was detected by the ISFET and shown in Fig. 10. These 
valued cover the physiological range of urea in human blood 
(2.5 mM – 7.8 mM) [34]. Glucose quantification has been 
also achieved using the same sensing modality [23].  
 
D. Simultaneous Assay 
Since the sensors can be independently addressed, different 
modalities can be used at the same time. In [35], we 
demonstrated that the Multicorder platform can operate both 
colorimetric and pH sensing to simultaneously quantify 
glucose and cholesterol. In [32], we also demonstrate that 
physical separations fabricated on top of the sensing area 
enable the use of the Multicorder for simultaneous enzyme-
based assays of multiple metabolites. Multiplexing 
immunoassays on the top of the Multicorder chip have also 
been demonstrated [36].  
 
V. CONCLUSION  
We have presented a CMOS-based multimodal sensor array 
for metabolites quantification.  
The colorimetric technique has been demonstrated by using 
PDs for the quantification of cholesterol in the physiological 
range. Chemiluminescence sensing has been demonstrated by 
employing SPADs for the quantification of urate in the 
physiological range. pH sensing performed by ISFETs also 
shown the suitability of the chip to quantify urea. SPR 
measurements have also been demonstrated on the same 
platform in related works [28, 29]. Multimode multiplexing 
and simultaneous assays have also been achieved [32, 35, 36]. 
Altogether, the chip demonstrated to be suitable for four 
different sensing techniques to be used independently or 
simultaneously. Future work includes the integration of 
additional sensing modalities into the platform [37]. 
We believe this platform could enable a new generation of 
commercial devices for low-cost, rapid and accurate 
diagnostics.  
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